ASPN
ASPN
NYSE · Chemicals

Aspen Aerogels Inc

$5.06
-0.27 (-5.07%)
Financial Highlights (FY 2026)
Revenue
282.62M
Net Income
-406,106,824
Gross Margin
17.0%
Profit Margin
-143.7%
Rev Growth
+14.5%
D/E Ratio
0.51
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 17.0% 17.0% 57.3% 57.3%
Operating Margin -139.5% -125.6% 18.7% 16.7%
Profit Margin -143.7% -136.5% 13.6% 15.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 282.62M 246.74M 146.35M 128.99M
Gross Profit 47.96M 41.87M 83.93M 73.97M
Operating Income -394,282,013 -309,807,762 27.30M 21.58M
Net Income -406,106,824 -319,099,128 19.84M 19.55M
Gross Margin 17.0% 17.0% 57.3% 57.3%
Operating Margin -139.5% -125.6% 18.7% 16.7%
Profit Margin -143.7% -136.5% 13.6% 15.2%
Rev Growth +14.5% +14.5% +7.3% +15.1%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 81.10M 81.10M 91.90M 96.56M
Total Equity 160.08M 160.08M 125.53M 123.58M
D/E Ratio 0.51 0.51 0.73 0.78
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -345,358,592 -286,441,996 43.43M 31.39M
Free Cash Flow 18.52M 15.91M